26 reports of this reaction
2.4% of all OXYMETAZOLINE HCL reports
#4 most reported adverse reaction
FATIGUE is the #4 most commonly reported adverse reaction for OXYMETAZOLINE HCL, manufactured by Wal-Mart Stores Inc. There are 26 FDA adverse event reports linking OXYMETAZOLINE HCL to FATIGUE. This represents approximately 2.4% of all 1,077 adverse event reports for this drug.
Patients taking OXYMETAZOLINE HCL who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for OXYMETAZOLINE HCL, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for OXYMETAZOLINE HCL:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 26 FDA reports for OXYMETAZOLINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.4% of all adverse event reports for OXYMETAZOLINE HCL, making it a notable side effect.
If you experience fatigue while taking OXYMETAZOLINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.